The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 0 pharmacodynamic study of dasatinib in women with newly diagnosed endometrial cancer.
 
Linda R. Duska
Research Funding - Aeterna Zentaris (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Millennium (Inst); Millennium (Inst)
Other Relationship - Genentech
 
Heather Lothamer
Research Funding - GlaxoSmithKline (Inst); Millennium (Inst); NRG Oncology (Inst)
 
William Faust
No Relationships to Disclose
 
Gina R. Petroni
No Relationships to Disclose
 
Paula M. Fracasso
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
Consulting or Advisory Role - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Sarah Parsons
No Relationships to Disclose